|
|
 |
|
Total Number of Holdings (excluding cash): 50
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
5,685 |
$80,441.79 |
3.95% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$58,275.35 |
2.86% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,997 |
$56,358.43 |
2.77% |
| Insulet Corporation |
PODD |
45784P101 |
148 |
$49,155.24 |
2.41% |
| ResMed Inc. |
RMD |
761152107 |
177 |
$48,250.20 |
2.37% |
| Agilent Technologies, Inc. |
A |
00846U101 |
372 |
$47,314.68 |
2.32% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
37 |
$47,215.70 |
2.32% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
183 |
$47,278.05 |
2.32% |
| Cochlear Limited |
COH.AU |
Q25953102 |
232 |
$46,813.26 |
2.30% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,655 |
$46,516.88 |
2.28% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
597 |
$46,255.56 |
2.27% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
160 |
$45,161.60 |
2.22% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
850 |
$44,999.00 |
2.21% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
212 |
$44,073.95 |
2.16% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
766 |
$43,268.67 |
2.12% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,122 |
$42,601.19 |
2.09% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$42,479.69 |
2.09% |
| DexCom, Inc. |
DXCM |
252131107 |
553 |
$42,332.15 |
2.08% |
| Steris Plc |
STE |
G8473T100 |
171 |
$42,406.29 |
2.08% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,881 |
$42,257.66 |
2.07% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
87 |
$41,824.38 |
2.05% |
| Hologic, Inc. |
HOLX |
436440101 |
651 |
$41,227.83 |
2.02% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
545 |
$40,924.05 |
2.01% |
| BioMerieux |
BIM.FP |
F1149Y232 |
303 |
$40,749.28 |
2.00% |
| Stryker Corporation |
SYK |
863667101 |
107 |
$40,298.34 |
1.98% |
| Abbott Laboratories |
ABT |
002824100 |
299 |
$39,695.24 |
1.95% |
| Boston Scientific Corporation |
BSX |
101137107 |
401 |
$39,690.98 |
1.95% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
132 |
$39,601.68 |
1.94% |
| Danaher Corporation |
DHR |
235851102 |
206 |
$39,236.82 |
1.93% |
| Olympus Corporation |
7733.JP |
J61240107 |
2,940 |
$37,543.51 |
1.84% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
321 |
$37,198.94 |
1.83% |
| Penumbra, Inc. |
PEN |
70975L107 |
138 |
$36,288.48 |
1.78% |
| Teleflex Incorporated |
TFX |
879369106 |
288 |
$36,236.16 |
1.78% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
364 |
$36,079.68 |
1.77% |
| Waters Corporation |
WAT |
941848103 |
118 |
$35,763.44 |
1.76% |
| Masimo Corporation |
MASI |
574795100 |
246 |
$35,178.00 |
1.73% |
| Becton, Dickinson and Company |
BDX |
075887109 |
187 |
$34,821.27 |
1.71% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
360 |
$34,120.60 |
1.68% |
| Revvity, Inc. |
RVTY |
714046109 |
400 |
$34,112.00 |
1.67% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
406 |
$33,572.14 |
1.65% |
| Alcon Inc. |
ALC.SW |
H01301128 |
428 |
$33,377.78 |
1.64% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
76 |
$33,022.00 |
1.62% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,873 |
$32,519.44 |
1.60% |
| The Cooper Companies, Inc. |
COO |
216648501 |
493 |
$32,123.88 |
1.58% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
624 |
$31,895.25 |
1.57% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,860 |
$32,005.87 |
1.57% |
| Baxter International Inc. |
BAX |
071813109 |
1,322 |
$31,556.14 |
1.55% |
| Align Technology, Inc. |
ALGN |
016255101 |
232 |
$30,582.24 |
1.50% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
524 |
$30,308.16 |
1.49% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
1,934 |
$24,895.05 |
1.22% |
| US Dollar |
$USD |
|
6,592 |
$6,592.33 |
0.32% |
| Yuan Renminbi |
$CNY |
|
1,990 |
$279.68 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|